4 Megakaryocytes and platelets in myeloproliferative disorders

Abgrall, 1991, Inhibitory effect of highly purified human beta thromboglobulin on in vitro human megakaryocyte colony formation, Experimental Hematology, 19, 202 Alexander, 1996, Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl, Blood, 87, 2162, 10.1182/blood.V87.6.2162.bloodjournal8762162 Barbui, 1983, Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function, European Journal of Cancer and Clinical Oncology, 19, 1593, 10.1016/0277-5379(83)90091-3 Barbui, 1996, Treatment strategies in essential thrombocythemia, Leukemia and Lymphoma, 22, 149, 10.3109/10428199609074373 Bartley, 1994, Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl, Cell, 77, 1117, 10.1016/0092-8674(94)90450-2 Bazzan, 1993, Fibrinolytic imbalance in essential thrombocythemia: role of platelets, Haemostasis, 23, 38 Belluci, 1986, Essential thrombocythemias: clinical evolutionary and biological data, Cancer, 58, 2440, 10.1002/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y Bellucci, 1993, Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF, Thrombosis and Haemostasis, 70, 736, 10.1055/s-0038-1649661 Budde, 1993, Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma, Blood, 82, 1749, 10.1182/blood.V82.6.1749.1749 Buhr, 1992, The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia, Virchows Archiv A: Pathological Anatomy and Histopathology, 420, 473, 10.1007/BF01600251 Busque, 1993, Clonal evolution in acute myeloid leukemia, Blood, 82, 337, 10.1182/blood.V82.2.337.bloodjournal822337 Cancelas, 1994, High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis, Thrombosis Research, 75, 513, 10.1016/0049-3848(94)90226-7 Castro-Malaspina, 1984, Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components, 427 Castro-Malaspina, 1982, Characteristics of bone-marrow fibroblast colony forming cells and their progeny in patients with myelo-proliferative disorders, Blood, 59, 1046, 10.1182/blood.V59.5.1046.1046 Chen, 1995, Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin, Blood, 86, 4054, 10.1182/blood.V86.11.4054.bloodjournal86114054 Cortelazzo, 1995, Hydroxyurea in the treatment of patients with essential thrombocythemia at high risk of thrombosis: a prospective randomized trial, New England Journal of Medicine, 332, 1132, 10.1056/NEJM199504273321704 El Kassar, 1995, Clonality analysis in essential thrombocythemia: advantages of studying platelets and T lymphocytes, Blood, 86, 183 Fialkow, 1981, Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell, Blood, 58, 916, 10.1182/blood.V58.5.916.916 Fielder, 1996, Regulation of thrombopoietin levels by c-mplmediated binding to platelets, Blood, 87, 2154, 10.1182/blood.V87.6.2154.bloodjournal8762154 Gale, 1993, Clonal analysis using X-linked DNA polymorphisms, British Journal of Haematology, 85, 2, 10.1111/j.1365-2141.1993.tb08637.x Gale, 1994, Tissue specificity of X-chromosome inactivation patterns, Blood, 83, 2899, 10.1182/blood.V83.10.2899.2899 Van Genderen, 1994, Lypooxygenase deficiency in primary thrombocythemia is not a true deficiency, Thrombosis and Haemostasis, 71, 803, 10.1055/s-0038-1642531 Van Genderen, 1995, Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin, Thrombosis and Haemostasis, 73, 210, 10.1055/s-0038-1653752 Georgii, 1990, Chronic myeloproliferative disorders in bone marrow biopsies, Pathology Research Practice, 186, 3, 10.1016/S0344-0338(11)81008-3 Georgii, 1996, Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies, Leukemia and Lymphoma, 22, 15, 10.3109/10428199609074357 Gewirtz, 1983, In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man, Blood, 61, 384, 10.1182/blood.V61.2.384.384 Gewirtz, 1995, Chemokine regulation of human megakaryocytopoiesis, Blood, 86, 2559, 10.1182/blood.V86.7.2559.2559 Green, 1996, Clonality assays in essential thrombocythemia and polycythemia vera: biological and clinical implications Gurney, 1994, Thrombocytopenia in c-mpl deficient mice, Science, 265, 1445, 10.1126/science.8073287 Han, 1989, Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system, Experimental Hematology, 17, 46 Han, 1990, Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura, British Journal of Haematology, 74, 395, 10.1111/j.1365-2141.1990.tb06325.x Han, 1990, Platelet factor 4 inhibits human megakaryocytopoiesis in vitro, Blood, 75, 1234, 10.1182/blood.V75.6.1234.1234 Han, 1992, Inhibitory effect of platelet factor four (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4, Journal of Laboratory and Clinical Medicine, 120, 645 Handa, 1995, Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (a2b1 integrin) deficiency associated with a myeloproliferative disorder, Thrombosis and Haemostasis, 73, 521, 10.1055/s-0038-1653807 Harker, 1968, Kinetics of thrombopoiesis, Journal of Clinical Investigations, 47, 458, 10.1172/JCI105742 Hoffman, 1991, Primary thrombocythemia, 881 Hoffman, 1981, Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies, New England Journal of Medicine, 305, 333, 10.1056/NEJM198109033051001 Ishibashi, 1987, Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro, Blood, 69, 1737, 10.1182/blood.V69.6.1737.1737 Jacobson, 1978, Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis, Blood, 51, 189, 10.1182/blood.V51.2.189.189 Jacobson, 1996, Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis, European Journal of Haematology, 56, 287, 10.1111/j.1600-0609.1996.tb00717.x Jiang, 1994, Cytokine production by primary bone marrow megakaryocytes, Blood, 84, 4151, 10.1182/blood.V84.12.4151.bloodjournal84124151 Juvonen, 1993, Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications, British Journal of Haematology, 83, 192, 10.1111/j.1365-2141.1993.tb08271.x Kanz, 1990, Analysis of megakaryocyte ploidy in patients with thrombocytosis, International Journal of Cell Cloning, 8, 299, 10.1002/stem.5530080415 Kaushansky, 1995, Thrombopoietin: the primary regulator of platelet production, Blood, 86, 419, 10.1182/blood.V86.2.419.bloodjournal862419 Kaywin, 1978, Platelet function in essential thrombocythemia: increased epinephrine responsiveness associated with a deficiency of platelet α-adrenergic receptors, New England Journal of Medicine, 299, 505, 10.1056/NEJM197809072991002 Kiladjian, 1995, New mRNA isoforms of the c-mpl receptor in human platelets, Blood, 88, 366a Kiladjian, 1996, The thrombopoietin receptor mRNA is overexpressed in essential thrombocythemia (ET), British Journal of Haematology Kimura, 1987, Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalities of bone marrow CFU-Meg, American Journal of Hematology, 24, 23, 10.1002/ajh.2830240104 Kimura, 1988, Effects of platelet derived growth factor, epidermal growth factor and transformaing growth factor-β on the growth of human marrow fibroblasts, British Journal of Haematology, 69, 9, 10.1111/j.1365-2141.1988.tb07595.x Kobayashi, 1993, Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3, British Journal of Haematology, 83, 539, 10.1111/j.1365-2141.1993.tb04688.x Komatsu, 1986, Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: effect of plasma and serum on megakaryocytic colony formation, British Journal of Haematology, 64, 241, 10.1111/j.1365-2141.1986.tb04116.x Kuter, 1990, Regulation of megakaryocyte ploidy in vivo in the rat, Blood, 75, 74, 10.1182/blood.V75.1.74.74 Kutti, 1996, Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis, Leukemia and Lymphoma, 22, 41, 10.3109/10428199609074359 Landolfi, 1992, Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo, Blood, 80, 1965, 10.1182/blood.V80.8.1965.1965 Lazlo, 1975, Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia, Seminars in Hematology, 12, 409 Legrand, 1991, Platelet thrombospondin and glycoprotein IV abnormalities in patients with essential thrombocythemia: effect of α-interferon treatment, American Journal of Haematology, 38, 307, 10.1002/ajh.2830380410 Lemoine, 1986, A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia, Blood, 68, 996, 10.1182/blood.V68.5.996.996 Li, 1994, Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF, British Journal of Haematology, 87, 471, 10.1111/j.1365-2141.1994.tb08300.x Li, 1995, Spontaneous CFU-MK formation in essential thrombocythemia (ET) is not due to autocrine secretion and disappears with cellular dilution and use of selected CD34+ cells, Blood, 86, 489 Li, 1996, Clonality assays and megakaryocyte culture techniques in essential thrombocythemia, Leukemia and Lymphoma, 22, 31, 10.3109/10428199609074358 Li, 1996, Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders, British Journal of Haematology, 92, 60, 10.1046/j.1365-2141.1996.00297.x Lok, 1994, Cloning and expression of murine thrombopoietin cDNA and stimulation of platlet production in vivo, Nature, 369, 565, 10.1038/369565a0 Malpass, 1984, Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders, Journal of Laboratory and Clinical Medicine, 103, 894 Martyré, 1991, Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia, British Journal of Haematology, 77, 80, 10.1111/j.1365-2141.1991.tb07952.x Mazur, 1988, Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia, Blood, 71, 1544, 10.1182/blood.V71.6.1544.1544 Michiels, 1994, Criteria for the clinico-pathological diagnosis of primary thrombocythaemia Michiels, 1985, Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia, Annals of Internal Medicine, 102, 466, 10.7326/0003-4819-102-4-466 Moore, 1981, Platelet Fc receptor: increased expression in myeloproliferative disease, Journal of Clinical Investigation, 67, 1064, 10.1172/JCI110118 Najean, 1990, Clinical significance of serum pro-collagen III in chronic myeloproliferative disorders, European Journal of Haematology, 45, 239, 10.1111/j.1600-0609.1990.tb00467.x Nurden, 1993, Markers of platelet activation in vivo, Nouvelle Revue Française d'Hématologie, 35, 251 Nurden, 1996, Platelet activation and thrombosis: studies in a patient with essential thrombocythemia, American Journal of Haematology, 51, 79, 10.1002/(SICI)1096-8652(199601)51:1<79::AID-AJH13>3.0.CO;2-6 Prachal, 1993, A novel clonality assay based on transcriptional analysis of the active X-chromosome, Stem Cells, 11, 62, 10.1002/stem.5530110613 Raskind, 1985, Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia, Journal of Clinical Investigation, 75, 1388, 10.1172/JCI111840 Rintelen, 1996, Factor V Leiden mutation is possibly an additional risk for venous thromboembolism in essential thrombocythemia and polycythemia vera de Sauvage, 1994, Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand, Nature, 369, 533, 10.1038/369533a0 de Sauvage, 1995, Deficiencies in early and late stages of megakaryocytopoiesis in TPO-KO mice, Blood, 86, 255a Sawyer, 1994, Circulating megakaryocytic progenitor cells in patients with primary thrombocythaemia and reactive thrombocytosis: results using a serumdeprived culture assay and a positive detection technique, European Journal of Haematology, 53, 108, 10.1111/j.1600-0609.1994.tb01873.x Schafter, 1982, Deficiency of platelet lipooxygenase activity in myeloproliferative disorders, New England Journal of Medicine, 306, 381, 10.1056/NEJM198202183060701 Schafer, 1984, Bleeding and thrombosis in the myeloproliferative disorders, Blood, 64, 1, 10.1182/blood.V64.1.1.1 Sehayek, 1988, Platelet parameters and aggregation in essential and reactive thrombocytosis, American Journal of Clinical Pathology, 90, 431, 10.1093/ajcp/90.4.431 Solberg, 1985, Characterization of human megakaryocytic colony formation in human plasma, Journal of Cell Physiology, 124, 67, 10.1002/jcp.1041240112 Souyri, 1990, A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors, Cell, 63, 1137, 10.1016/0092-8674(90)90410-G Taylor, 1995, Inappropriate elevation and loss of feedback regulation of thrombopoietin in essential thrombocythaemia, Blood, 86 Terui, 1990, The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis, Blood, 75, 1540, 10.1182/blood.V75.7.1540.1540 Thibert, 1992, Quantitation of platelet glycoprotein IV (CD 36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay, Thrombosis and Haemostasis, 68, 600, 10.1055/s-0038-1646324 Thiele, 1990, An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML), European Journal of Haematology, 44, 63, 10.1111/j.1600-0609.1990.tb00349.x Thiele, 1992, Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow, British Journal of Haematology, 80, 227, 10.1111/j.1365-2141.1992.tb08905.x Tomer, 1989, Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts, Blood, 74, 594, 10.1182/blood.V74.2.594.594 Tsukamoto, 1994, Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement, British Journal of Haematology, 86, 253, 10.1111/j.1365-2141.1994.tb04723.x Ushikubi, 1992, Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera, Thrombosis and Haemostasis, 67, 144, 10.1055/s-0038-1648396 Vainchenker, 1982, Normal human serum contains α factor(s) capable of inhibiting megakaryocyte colony formation, Experimental Hematology, 10, 650 Vigon, 1992, Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a membrane of the hematopoietic growth factor receptor superfamily, 89, 5640 Wang, 1992, Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia, British Journal of Haematology, 80, 184, 10.1111/j.1365-2141.1992.tb08898.x Westwood, 1996, Diagnostic application of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias, Leukemia and Lymphoma, 22, 95, 10.3109/10428199609074366 Wickenhauser, 1995, Secretion of cytokines (interleukins-1α, -3 and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes, Blood, 85, 685, 10.1182/blood.V85.3.685.bloodjournal853685 Yamauchi, 1994, Pulmonary fibrosis with megakaryocytoid cell infiltration and chronic myelogenous leukemia, Leukemia and Lymphoma, 15, 253, 10.3109/10428199409049721 Zauli, 1991, Essential thrombocythemia: impaired regulation of megakaryocyte progenitors, International Journal of Cell Cloning, 9, 43, 10.1002/stem.5530090107 Zauli, 1993, Reduced responsiveness of bone marrow megakaryocyte progenitors of platelet-derived transforming growth factor β1, produced in normal amount, in patients with essential thrombocythemia, British Journal of Haematology, 83, 14, 10.1111/j.1365-2141.1993.tb04624.x